NKTR Q1 2026 Earnings WiderThanExpected Loss on No Revenue Atea Pharmaceuticals Q1 2026 Earnings Narrower Loss Beats Expectations Stock Edges Higher SQFTP Q3 2023 Earnings Preferred Stock Reports Negative EPS Amidst Stable Performance Textron Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction BBLG Q1 2026 Earnings NarrowerthanExpected Loss as Bone Biologics Advances Development BZH Q1 2026 Earnings Significant EPS Surprise Despite Narrow Loss